Transforming molecular information
Go to content
Contact
IntegraGen on Twitter
IntegraGen on LinkedIn
IntegraGen - RSS feed
About Us
Company Overview
Management Team
Board of Directors
IntegraGen Genomics
Oncology
Colorectal Cancer
Scientific Advisors
miR‐31‐3p and colorectal cancer
Publications
Hepatocellular Carcinoma
Molecular signature for liver cancer
Lung cancer
miR-31-3p and lung cancer
ICE Project
Oncology News
Autism
What is Autism Spectrum Disorder?
The Genetics of Autism
The ARISk Test
Autism Publications
News and Events
Press releases
Latest News
Upcoming Events
Investors
Corporate Presentations
Press releases
Share Information
Calendar for Publications
Financial Documents
Financial Reports
Liquidity Contract
Shareholder Meetings
Investor Contacts
Join our mailing list
Contact Us
Office locations
Need Directions?
Contact form
Join our mailing list
Careers
IntegraGen presents positive data at 2016 ASCO meeting on the role of microRNA biomarker miR-31-3p
Learn more »
Experts in genome analysis
and bioinformatics
Learn more »
Helping to personalize the care of cancer patients
Oncology biomarker discovery and development
Learn more »
IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for autism and oncology.
Genomic Services
"Helping you to find"
Learn more
Oncology Biomarkers
Explore our efforts to identify genetic markers which can help to personalize cancer care
Learn more
Investors
Learn more
Latest news
// Archive
News
New data on miR-31-3p biomarker to be featured during oral presentation at 2016 ESMO Congress
Press releases
IntegraGen reports strong revenue growth during first half of 2016
Press releases
AP-HP and IntegraGen agree to develop a common platform for high-throughput sequencing
